Progression in acute ischemic stroke: Frequency, risk factors and prognosis

Journal of Clinical Neuroscience

Volumn 10, Issue 2, 2003, Pages 177-180

  Sumer, Murat ^a,c   Ozdemir, Iklim ^b   Erturk, Ozcan ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Bayindir Medical Center   (Turkey)

^c NONE   (Turkey)

Author keywords

Stroke acute; Stroke classification; Stroke outcome

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; EMBOLISM; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SMOKING; TRANSIENT ISCHEMIC ATTACK;

EID: 0037344179     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(02)00325-9     Document Type: Article

References (44)

1. Röden-Jüllig A. Progressing stroke: epidemiology. Cerebrovasc Dis 1997; 7(Suppl 5): 2-5.
2. Donnan GA, Dewey H. Davis SM, Thrift A. Acute brain infarction: early changes in neurological status. Cerebrovasc Dis 1997; 7(Suppl 5): 6-9.
3. Toni D. Predictors of stroke deterioration. Cerebrovasc Dis 1997; 7(Suppl 5): 10-13.
4. Caplan LR. Treatment of "progressive" stroke. Stroke 1991; 22(5): 694-695.
5. Davalos A, Centra E. Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990; 40: 1865-1869.
6. Asplund K. Any progress on progressing stroke? Cerebrovasc Dis 1992; 2: 317-319.
7. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000; 31: 2049-2054.
8. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ. Progressing in acute stroke: value of initial NIH Stroke Scale score on the patients stratification in future trials. Stroke 1999; 30: 1208-1212.
9. Castillo J, Davalos A, Noya M. Progression of ischemic stroke and excitotoxic amino acids, Lancet 1997; 349: 79-83.
10. Cote R, Hachinski VC. Shurvell BL, Norris JW, Wolfson C. The Canadian neurological scale: a preliminary study in acute stroke. Stroke 1986; 17: 731-737.
11. Fiorelli M, Alperovitch A, Argentino C, Sachetti ML, Toni D, Sette G et al., for the Italian Acute Stroke Study Group. Prediction of long term-outcome in the early hours following acute ishemic stroke. Arch. Neurol. 1995; 52: 250-255.
12. Cote R, Battista RN, Wolfson C, Boucher J, Adams J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989; 39: 638-643.
13. Rankin J. Cerebral vascular accidents in patients over the age of 60: prognosis. Scott Med J 1957; 2: 200-215.
14. Davalos A, Castillo J, Marrugat J, Fernandez-Real JM, Armengou A, Cacabelos Rama R. Body iron stores and early neurological deterioration in acute cerebral infarction. Neurology 2000; 54: 1568-1574.
15. Adams Jr HP, Bendixen BH, Kapelle JL, Biller J, Love BB, Gordon DL et al., and the TOAST investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41.
16. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C et al. Progressing neurological deficits secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol 1995; 52: 670-675.
17. Jorgensen HS, Nakayama H, Raaschou Ho, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344: 156-159.
18. Asplund K. Deterioration of acute stroke. In: Del Zoppo, et al. (eds) Thrombolytic Therapy in Acute Ischemic Stroke II. Springer, Berlin 1993; 119-128.
19. Nakamura K, Saku Y, Ibayashi S, Fujishima M. Progressive motor deficits in lacunar infarction. Neurology 1999; 52: 29-33.
20. Serena J, Leira R, Castillo J, Pumar JM, Castellanos M, Davalos A. Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotmnsmitters. Stroke 2001; 32: 1154-1161.
21. Arboix A, Garcia-Eroles E, Massons JB. Oliveres M, Pujades R, Targa C. Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherotrombotic infarction. Int J Cardiol 2000; 31: 33-42.
22. Arboix A, Oliveres M, Massons J, Pujades R, Garcia-Eroles E. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol 1999; 6: 677-683.
23. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978; 28: 754-762.
24. Urbinelli R, Bolard P, Lemesle M, Osseby GV, Thomas V, Boruel D, Megherbi SE, Giroud A, Wolf JE, Giroud M. Stroke patterns in cardio-embolic infarction in a population-based study. Neurol Res 2001; 23(4): 309-314.
25. Oishi M, Mochizuki Y, Shikata E, Mizutani T. Acetazolamide reactivity in atherothrombotic, cardioembolic and lacunar infarctions. Keio J Med 2000; 49(Suppl 1): A117-119.
26. Hinchey JA. Furlan AJ, Barnett HJM. Cardiogenic brain embolism: incidence, varieties and treatment. In: Barnett HJM (ed) Stroke: Pathophysiology, Treatment and Prognosis. third ed. Churchill Livingstone, Philadelphia, PA 1998; 1089-1120.
27. Fisher M, Garcia JH. Evolving stroke and ischemic penumbra. Neurology 1996; 47: 884-888.
28. Yamamoto H, Bogousslavsky J, Melle G. Different predictors of neurological worsening in different causes of stroke. Arch Neurol 1998; 55: 481-486.
29. Jones HR, Millikan CH, Sandok BA. Temporal profile (clinical course) of acute vertebrobasiler system cerebral infarction. Stroke 1980; 11: 173-177.
30. Tei H, Uchiyama S, Koshimizu K, Kobayashi M, Ohara K. Correlation between symptomatic, radiological and etiological diagnosis in acute ischemic stroke. Acta Neurol Scand 1999; 99: 192-195.
31. Graf KJ, Pessin MS, DeWitt LD, Caplan LR. Proximal intracranial territory posterior circulation infarcts in the New England Medical Center Posterior Circulation Registry. Eur Neurol 1997; 37: 157-168.
32. Bogousslavsky J, Regli F, Maeder P, Meuli R, Nader J. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology 1993; 43: 1528-1533.
33. Caplan LR, Amarenco P, Rosengart A, Lafranchise EF, Teal PA, Belkin M et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992; 42: 1505-1512.
34. Lee BI, Nam HS, Heo JH, Kim DI. The Yonsei Stroke Team. Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis 2001; 12: 145-151.
35. Takagi K, Ginsberg MD, Globus MY, Dietrich WD, Martinez E, Kraydieh S et al. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 1993; 13: 575-585.
36. Gauthier JC. Stroke-in-progression. Stroke 1985; 16: 729-733.
37. Uchiyama S, Yamazaki M, Hara Y, Iwata M. Alterations of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke. Semin Tromb Hemost 1997; 23: 535-541.
38. Millikan CH, McDowell FH. Treatment of progressing stroke. Stroke 1981; 12: 397-409.
39. Haley Jr EC, Kassel NF, Torner JC. Failure of heparin to prevent progression in progressing ischemic infarction. Stroke 1988; 19: 10-14.
40. Sage JI. Stroke: the use and overuse of heparin in therapeutic trials. Arch Neurol 1985; 42: 315-317.
41. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Trial (ECASS) 1. Stroke 1999; 30: 2631-2636.
42. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC, for the RANTTAS investigators. Infarct Volume as a Surrogate or Auxiliary Outcome Measure in Ischemic Stroke Clinical Trials. Stroke 1999; 30: 293-298.
43. Johnston KC, Wagner DP, Haley Jr EC, Connors Jr AF. RANTTAS Investigators. Randomized Trial of Tirilazad Mesylate in Acute Stroke. Combined clinical and imaging information as an early stroke outcome measure. Stroke 2002; 33: 466-472.
44. Brott T, Marler JR, Olinger CP, Adams HP, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurement of Acute Cerebral Infarction: Lesion Size by Computed Tomography. Stroke 1989; 20: 871-875.